0RFI.L - BRAIN Biotech AG

LSE - LSE Prezzo differito. Valuta in EUR.

BRAIN Biotech AG

Darmstädter Strasse 34-36
Zwingenberg 64673
49 62 51 9331 0

Impiegati a tempo pieno316

Figure dirigenziali chiave

NomeTitoloRetribuzioneEsercitateAnno di nascita
Mr. Adriaan MoelkerChairman of the Management Board & CEO620kN/DN/D
Mr. Ulrich PutschCo-FounderN/DN/DN/D
Mr. Michael SchneidersCFO & Member of Management BoardN/DN/D1970
Dr. Ute DechertVP of HR & ProcessesN/DN/D1961
Dr. Jurgen EckConsultantN/DN/D1962
Dr. Martin LangerMD & Exec. VPN/DN/D1965
Thomas DeichmannHead of PRN/DN/DN/D
Dr. Alexander PelzerVP and Head of R&D - ZwingenbergN/DN/D1986
Mr. Robbert Michael HoekstraHead of Group Fin.N/DN/D1978
Mr. Paul ScholzTechnical Lead of Genome Editing Devel.N/DN/DN/D
Gli importi risalgono al giorno 31 dicembre 2021 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in EUR.


BRAIN Biotech AG offers Bio-based products and solutions in Germany, the United States, France, the Netherlands, and the United Kingdom. The company operates in two segments, BioScience and BioIndustrial. It offers enzymes and biocatalysts to produce food and beverages, wound care preparations or lubricants, and production of starch and bioethanol; bioactive natural compounds for product developments in the food, animal feed, skin care, chemical, and cosmetics industries; and microorganisms as the functional biomass for optimized industrial production processes, recycling of the greenhouse gas CO2 as an industrial raw material, and urban and green mining for extraction of precious and rare earth metals. The company also offers R&D services for contract research for product development and innovative solutions in the categories of enzymes, microbial production strains, and bioprocesses. The company was formerly known as B.R.A.I.N. Biotechnology Research and Information Network AG and changed its name to BRAIN Biotech AG in April 2021. BRAIN Biotech AG was founded in 1993 and is headquartered in Zwingenberg, Germany.

Governance aziendale

L'ISS Governance QualityScore di BRAIN Biotech AG al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.